Eton Pharmaceuticals, INC. (ETON) — 8-K Filings

8-K Filings (32)

• Eton Pharmaceuticals Appoints New CFO — Apr 16, 2026 Risk: low
  Eton Pharmaceuticals, Inc. announced on April 16, 2026, the appointment of a new Chief Financial Officer (CFO). The press release, filed as Exhibit 99.1, detail
• 8-K Filing — Dec 4, 2025
• Eton Pharmaceuticals Files 8-K — Jul 8, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on July 8, 2025, to report other events and financial statements. The filing does not contain specific details about the
• Eton Pharmaceuticals Files 8-K — Jun 27, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on June 27, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific
• Eton Pharmaceuticals Changes Auditors — Jun 20, 2025 Risk: low
  Eton Pharmaceuticals, Inc. announced on June 13, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered publ
• Eton Pharmaceuticals Files 8-K on Shareholder Votes — Jun 10, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on June 10, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's cor
• Eton Pharmaceuticals Files 8-K — May 28, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on May 28, 2025, reporting other events and financial statements. The filing does not contain specific details about the
• Eton Pharmaceuticals Files 8-K on Financials — May 13, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on May 13, 2025, reporting on its results of operations and financial condition, as well as filing financial statements
• Eton Pharmaceuticals Files 8-K — Apr 28, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on April 28, 2025, reporting other events and financial statements. The filing does not contain specific details about n
• Eton Pharmaceuticals Files 8-K for Financials and Exhibits — Apr 1, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on April 1, 2025, reporting on events that occurred on March 31, 2025. The filing primarily concerns financial statement
• Eton Pharmaceuticals Files 8-K — Mar 14, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on March 14, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specifi
• Eton Pharmaceuticals Files 8-K — Mar 3, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on March 3, 2025, reporting other events and financial statements. The filing details the company's principal executive
• Eton Pharmaceuticals Files 8-K — Feb 7, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on February 7, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain speci
• Eton Pharmaceuticals Files 8-K — Feb 6, 2025 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on February 6, 2025, reporting other events and financial statements. The filing details the company's corporate structu
• Eton Pharmaceuticals Completes 03 Life Sciences Acquisition — Jan 3, 2025 Risk: medium
  Eton Pharmaceuticals, Inc. announced the completion of its acquisition of 100% of the outstanding equity interests in 03 Life Sciences on December 31, 2024. Thi
• Eton Pharma Completes Asset Acquisition — Dec 20, 2024 Risk: medium
  Eton Pharmaceuticals, Inc. announced the completion of its acquisition of certain assets from 03 Life Sciences on December 19, 2024. The filing does not disclos
• Eton Pharmaceuticals to be Acquired by Luye Pharma Group — Dec 17, 2024 Risk: medium
  Eton Pharmaceuticals, Inc. announced on December 17, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of Luye Pharma Group L
• Eton Pharmaceuticals Enters Material Definitive Agreement — Dec 12, 2024 Risk: medium
  Eton Pharmaceuticals, Inc. announced on December 10, 2024, that it has entered into a material definitive agreement. The filing does not disclose specific detai
• Eton Pharmaceuticals Files 8-K — Dec 3, 2024 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on December 3, 2024, to report other events and financial statements. The filing does not contain specific details about
• Eton Pharmaceuticals Enters Material Definitive Agreement — Nov 25, 2024 Risk: medium
  Eton Pharmaceuticals, Inc. announced on November 22, 2024, that it entered into a material definitive agreement. The filing does not disclose specific details o
• Eton Pharmaceuticals Files 8-K — Nov 7, 2024 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on November 7, 2024, reporting on events that occurred on November 5, 2024. The filing primarily concerns other events a
• Eton Pharmaceuticals Enters Material Definitive Agreement — Oct 3, 2024 Risk: medium
  Eton Pharmaceuticals, Inc. announced on October 2, 2024, that it entered into a material definitive agreement. The filing does not disclose specific details of
• Eton Pharmaceuticals Files 8-K on Financials — Aug 8, 2024 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial stateme
• Eton Pharmaceuticals Files 8-K — Jul 15, 2024 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on July 15, 2024, to report other events and financial statements. The filing details the company's principal executive
• 3D Systems to Acquire Eton Pharmaceuticals for $1.2B — Jun 21, 2024 Risk: medium
  Eton Pharmaceuticals, Inc. announced on June 14, 2024, that it has entered into a definitive agreement to be acquired by 3D Systems Corporation for approximatel
• Eton Pharmaceuticals Files 8-K on Shareholder Votes — Jun 11, 2024 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on June 11, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's cor
• Eton Pharmaceuticals Files 8-K — Apr 30, 2024 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on April 30, 2024, reporting other events and financial statements. The filing does not contain specific financial figur
• Eton Pharmaceuticals Reports Unregistered Equity Sales — Apr 18, 2024 Risk: medium
  Eton Pharmaceuticals, Inc. filed an 8-K on April 18, 2024, reporting unregistered sales of equity securities. The filing details transactions that occurred on A
• Eton Pharmaceuticals Files 8-K — Mar 22, 2024 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on March 22, 2024, to report other events and financial statements. The filing does not contain specific details about n
• Eton Pharmaceuticals Files 8-K on Financials — Mar 14, 2024 Risk: low
  Eton Pharmaceuticals, Inc. filed an 8-K on March 14, 2024, reporting on its results of operations and financial condition. The filing includes financial stateme
• Eton Pharmaceuticals Files 8-K for 'Other Event' and Financial Exhibits — Feb 21, 2024 Risk: medium
  Eton Pharmaceuticals, Inc. filed an 8-K on February 21, 2024, reporting an "Other Event" and "Financial Statements and Exhibits." The filing indicates a current
• Eton Pharma Files Routine 8-K; No Major News Reported — Feb 2, 2024
  Eton Pharmaceuticals, Inc. filed an 8-K on February 2, 2024, to report 'Other Events' and 'Financial Statements and Exhibits.' This filing indicates standard, r

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX